Ophthalmic lens with a microfluidic system

Abstract

The present invention described a system for an energized ophthalmic device with a media insert that includes microfluidic elements upon or within the media insert. In some embodiments, the microfluidic elements may be useful for the purpose of analyzing an analyte such as glucose in a fluid sample. In addition, some embodiments can function with a medicament administering device to treat an abnormal condition identified during the analyte analysis in the fluid sample.

1 . A method of treating abnormal glucose levels, comprising:
 programming glucose biomarkers normal concentrations level thresholds;   placing an ophthalmic device in contact with an anterior ocular surface of an eye;   obtaining an ocular fluid sample using a microfluidic element of the ophthalmic device;   measuring one or more properties of the ocular fluid using one or more sensor components of the ophthalmic device;   processing the measurements of the one or more properties of the ocular fluid to determine whether the concentration of glucose biomarkers are within the preprogrammed thresholds; and   outputting a signal to a medicament dispensing device based on the measurement.   
     
     
         2 . The method of  claim 1 , additionally comprising:
 determining patterns in the changes of glucose concentrations corresponding to a time of the day.   
     
     
         3 . The method of  claim 1 , additionally comprising:
 alerting the user of an abnormal glucose level when the levels are outside the pre-programmed thresholds.   
     
     
         4 . The method of  claim 1 , additionally comprising:
 applying an algorithm to compensate for a time delay in the change of the measured properties to the condition causing the change.   
     
     
         5 . A method of treating abnormal glucose levels, comprising:
 programming glucose biomarkers normal concentrations level thresholds;   placing an ophthalmic device in contact with an anterior ocular surface of an eye;   obtaining an ocular fluid sample using a microfluidic element of the ophthalmic device;   measuring one or more properties of the ocular fluid using one or more sensor components of the ophthalmic device;   applying an algorithm to compensate for a time delay in the change of the measured properties to a condition causing the abnormal level;   processing the measurements of the one or more properties of the ocular fluid to determine whether the concentration of glucose biomarkers are within the preprogrammed thresholds; and   identifying the condition causing the change in glucose levels.   
     
     
         6 . The method of  claim 5 , additionally comprising:
 storing measured properties to be included as part of a user's medical history.